COVID vaccines
China's vaccine diplomacy spoiled by omicron variant
Sinopharm, Sinovac and CanSino Biologics exports fall 97% on poor protection
Global supplies shortage and dependence on West spell urgency, opportunity
Availability of shots for others still pending
Japanese drugmaker also says vaccine proven effective in trials
Jab, different from Pfizer and Moderna's mRNA vaccines, provides 'diversity'
Service will be offered to hotels and retailers, can verify vaccine records
Vaccination policies and need for stability delay shift to living with virus
Move comes amid steady rise in cases
Government aims to class COVID as 'endemic' by July, nightclubs kept shut for now
Country widens inoculations as schools reopen; daily cases dip below 5,000
China allows use of rapid antigen test kits; Japan considers offering fourth vaccine shot
Limited effectiveness of conventional shots puts 'zero-COVID' policy at risk
China sets annual economic growth target at 'around 5.5%'
Deliveries of COVID vaccine to start as early as May after trial success
China detects 100 imported cases from Hong Kong; Japan's Shionogi files for oral drug approval
African nations to receive mRNA vaccine tech; Hong Kong elections delayed by outbreak
Vaccine disparity in country of 17,000 islands casts shadow on recovery
City-state keeps 3-5% GDP target as boosters cover 64%, most infections mild
Taiwan, Malaysia also picked; CEO Bancel eyes vaccine plants in Asia
Vaccine mandates cast doubt on tennis star's chance to achieve record wins
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.